Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

A Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy with High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T.

Arthritis Rheumatol. 2019 Sep 16. doi: 10.1002/art.41105. [Epub ahead of print]

PMID:
31524333
2.

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis.

Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1621439. [Epub ahead of print]

PMID:
31116051
3.

Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation.

Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T.

J Immunol. 2019 Jun 1;202(11):3161-3172. doi: 10.4049/jimmunol.1801159. Epub 2019 Apr 24.

PMID:
31019063
4.

Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.

Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2019 Feb 21:1-5. doi: 10.1080/14397595.2019.1583819. [Epub ahead of print]

PMID:
30789095
5.

Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.

Kitagori K, Yoshifuji H, Oku T, Ayaki T, Kuzuya A, Nakajima T, Akizuki S, Nakashima R, Murakami K, Ohmura K, Hirayama Y, Takahashi R, Mimori T.

Lupus. 2019 Mar;28(3):414-422. doi: 10.1177/0961203319828818. Epub 2019 Feb 11.

PMID:
30744522
6.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

7.

Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.

Yoshifuji H.

Mod Rheumatol. 2019 Mar;29(2):287-293. doi: 10.1080/14397595.2018.1546358. Epub 2019 Feb 4. Review.

PMID:
30427262
8.

Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.

Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T.

Sci Rep. 2018 Jul 6;8(1):10262. doi: 10.1038/s41598-018-28405-x.

9.

Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report.

Takeuchi Y, Hashimoto M, Nakashima R, Tanaka M, Kuramoto N, Murakami K, Yoshifuji H, Ohmura K, Mimori T.

Rheumatol Adv Pract. 2018 Jun 23;2(2):rky022. doi: 10.1093/rap/rky022. eCollection 2018. No abstract available.

10.

Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease.

Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M.

Mod Pathol. 2018 Jun;31(6):890-899. doi: 10.1038/s41379-018-0036-4. Epub 2018 Feb 12.

11.

Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.

Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, Salah A, Nakajima T, Kiso K, Yamada N, Haga H, Tsuruyama T.

Arthritis Res Ther. 2018 Jan 30;20(1):13. doi: 10.1186/s13075-018-1511-5.

12.

Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.

Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M.

Mod Rheumatol. 2018 Sep;28(5):838-844. doi: 10.1080/14397595.2017.1416739. Epub 2018 Jan 8.

PMID:
29251035
13.

Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey.

Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T.

J Gastroenterol. 2018 Jul;53(7):845-853. doi: 10.1007/s00535-017-1420-4. Epub 2017 Dec 8.

PMID:
29222587
14.

Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice.

Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2018 Jul;28(4):626-636. doi: 10.1080/14397595.2017.1380249. Epub 2017 Oct 3.

PMID:
28972439
15.

Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.

Kiso K, Yoshifuji H, Oku T, Hikida M, Kitagori K, Hirayama Y, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A.

PLoS One. 2017 Sep 14;12(9):e0184738. doi: 10.1371/journal.pone.0184738. eCollection 2017.

16.

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.

Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.

Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.

17.

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.

Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C.

Sci Rep. 2017 Jul 31;7(1):6911. doi: 10.1038/s41598-017-07137-4.

18.

Osteopontin in systemic lupus erythematosus.

Kitagori K, Yoshifuji H.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):118-123. doi: 10.2177/jsci.40.118. Review. Japanese.

19.

High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach.

Salah A, Yoshifuji H, Ito S, Kitagori K, Kiso K, Yamada N, Nakajima T, Haga H, Tsuruyama T, Miyagawa-Hayashino A.

Patholog Res Int. 2017;2017:9312142. doi: 10.1155/2017/9312142. Epub 2017 May 16.

20.

Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.

Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K.

J Rheumatol. 2017 Sep;44(9):1384-1388. doi: 10.3899/jrheum.161432. Epub 2017 May 15.

PMID:
28507178
21.

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.

Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K.

Rheumatology (Oxford). 2017 Jul 1;56(7):1217-1226. doi: 10.1093/rheumatology/kex088.

22.

Clinical Images: Chronic Nonbacterial Osteomyelitis.

Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T.

Arthritis Rheumatol. 2017 Aug;69(8):1660. doi: 10.1002/art.40108. Epub 2017 Jul 5. No abstract available.

23.

Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis.

Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y.

Ann Rheum Dis. 2017 Jun;76(6):1150-1158. doi: 10.1136/annrheumdis-2016-210645. Epub 2017 Mar 17. Review.

24.

Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.

Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T.

Int J Rheum Dis. 2017 Jun;20(6):731-736. doi: 10.1111/1756-185X.13000. Epub 2017 Feb 15.

PMID:
28198158
25.

Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.

Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T.

PLoS One. 2016 Dec 19;11(12):e0167141. doi: 10.1371/journal.pone.0167141. eCollection 2016.

26.

Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.

Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T.

J Autoimmun. 2017 Feb;77:116-122. doi: 10.1016/j.jaut.2016.11.006. Epub 2016 Dec 3.

PMID:
27919567
27.

A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts.

Yamakawa N, Oe K, Yukawa N, Murakami K, Nakashima R, Imura Y, Yoshifuji H, Ohmura K, Miura Y, Tomosugi N, Kawabata H, Takaori-Kondo A, Mimori T.

Intern Med. 2016;55(18):2697-701. doi: 10.2169/internalmedicine.55.6565. Epub 2016 Sep 15.

28.

Cell-contact-dependent activation of CD4+ T cells by adhesion molecules on synovial fibroblasts.

Mori M, Hashimoto M, Matsuo T, Fujii T, Furu M, Ito H, Yoshitomi H, Hirose J, Ito Y, Akizuki S, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Mimori T.

Mod Rheumatol. 2017 May;27(3):448-456. doi: 10.1080/14397595.2016.1220353. Epub 2016 Sep 13.

PMID:
27623446
29.

Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients.

Tsuji H, Ohmura K, Nakashima R, Hashimoto M, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Mimori T.

Intern Med. 2016;55(12):1547-52. doi: 10.2169/internalmedicine.55.5553. Epub 2016 Jun 15.

30.

Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases.

Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F.

Rheumatology (Oxford). 2016 Sep;55(9):1686-92. doi: 10.1093/rheumatology/kew233. Epub 2016 May 30.

PMID:
27241705
31.

Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.

Hiramatsu S, Ohmura K, Tsuji H, Kawabata H, Kitano T, Sogabe A, Hashimoto M, Murakami K, Imura Y, Yukawa N, Yoshifuji H, Fujii T, Takaori-Kondo A, Mimori T.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(1):64-71. doi: 10.2177/jsci.39.64.

32.

Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease.

Imura Y, Yukawa N, Handa T, Nakashima R, Murakami K, Yoshifuji H, Ohmura K, Ishii H, Nakata K, Mimori T.

Mod Rheumatol. 2018 Jul;28(4):724-729. doi: 10.3109/14397595.2016.1153443. Epub 2016 Mar 11.

PMID:
26872621
33.

Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases--Possible Association with Vascular Disease and Seasonal Change.

Kono M, Miura N, Fujii T, Ohmura K, Yoshifuji H, Yukawa N, Imura Y, Nakashima R, Ikeda T, Umemura S, Miyatake T, Mimori T.

PLoS One. 2015 Dec 23;10(12):e0144952. doi: 10.1371/journal.pone.0144952. eCollection 2015.

34.

Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application.

Terao C, Yoshifuji H, Nakajima T, Yukawa N, Matsuda F, Mimori T.

Scand J Rheumatol. 2016 Jan;45(1):80-82. doi: 10.3109/03009742.2015.1060521. Epub 2015 Aug 31. No abstract available.

PMID:
26313121
35.

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease.

Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T.

BMC Musculoskelet Disord. 2015 May 28;16:129. doi: 10.1186/s12891-015-0584-4.

36.

Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap.

Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F.

Arthritis Rheumatol. 2015 May;67(8):2226-32. doi: 10.1002/art.39157.

37.

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.

Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A; Musashi Study Investigators.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1354-62. doi: 10.1002/acr.22598.

38.

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Yoshifuji H.

Clin Med Insights Circ Respir Pulm Med. 2016 Apr 3;9(Suppl 1):141-6. doi: 10.4137/CCRPM.S36748. eCollection 2015. Review.

39.

Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8.

Shiheido H, Kitagori K, Sasaki C, Kobayashi S, Aoyama T, Urata K, Oku T, Hirayama Y, Yoshitomi H, Hikida M, Yoshifuji H, Mimori T, Watanabe T, Shimizu J.

Immun Inflamm Dis. 2014 Jun;2(1):35-43. doi: 10.1002/iid3.17. Epub 2014 Feb 19.

40.

Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis.

Nakajima T, Kawabata D, Nakabo S, Miyagawa-Hayashino A, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Mimori T.

Intern Med. 2014;53(19):2255-8.

41.

Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis.

Tsuji H, Yoshifuji H, Fujii T, Matsuo T, Nakashima R, Imura Y, Yukawa N, Ohmura K, Sumiyoshi S, Mimori T.

Mod Rheumatol. 2017 Jan;27(1):155-161. doi: 10.3109/14397595.2014.948981. Epub 2014 Aug 27.

PMID:
25159158
42.

[Susceptibility HLA alleles and amino acids to Takayasu arteritis].

Terao C, Yoshifuji H, Mimori T, Matsuda F.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(3):166-70. Japanese.

43.

Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets.

Yamamoto N, Yamaguchi H, Ohmura K, Yokoyama T, Yoshifuji H, Yukawa N, Kawabata D, Fujii T, Morita S, Nagata S, Mimori T.

Lupus. 2014 Apr;23(4):386-94. doi: 10.1177/0961203314523870. Epub 2014 Feb 19. Erratum in: Lupus. 2015 Nov;24(13):NP5.

PMID:
24554711
44.

Recent advances in Takayasu arteritis.

Terao C, Yoshifuji H, Mimori T.

Int J Rheum Dis. 2014 Mar;17(3):238-47. doi: 10.1111/1756-185X.12309. Epub 2014 Feb 18. Review.

PMID:
24548718
45.

Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus.

Yokoyama T, Fujii T, Kondo-Ishikawa S, Yamakawa N, Nakano M, Yukawa N, Yoshifuji H, Ohmura K, Mimori T.

Lupus. 2014 Jun;23(7):635-42. doi: 10.1177/0961203314522337. Epub 2014 Feb 3.

46.

Inverse association between air pressure and rheumatoid arthritis synovitis.

Terao C, Hashimoto M, Furu M, Nakabo S, Ohmura K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Matsuda F, Ito H, Fujii T, Mimori T.

PLoS One. 2014 Jan 15;9(1):e85376. doi: 10.1371/journal.pone.0085376. eCollection 2014.

47.

[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].

Yoshifuji H, Kinoshita H.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):454-61. doi: 10.2177/jsci.37.454. Review. Japanese.

48.

Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases.

Tanaka K, Terao C, Ohmura K, Takahashi M, Nakashima R, Imura Y, Yoshifuji H, Yukawa N, Usui T, Fujii T, Mimori T, Matsuda F.

J Hum Genet. 2014 Feb;59(2):107-9. doi: 10.1038/jhg.2013.129. Epub 2013 Dec 19.

49.

A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.

Yamakawa N, Fujimoto M, Kawabata D, Terao C, Nishikori M, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Ohmura K, Fujii T, Kitano T, Kondo T, Yurugi K, Miura Y, Maekawa T, Saji H, Takaori-Kondo A, Matsuda F, Haga H, Mimori T.

J Rheumatol. 2014 Feb;41(2):293-9. doi: 10.3899/jrheum.130270. Epub 2013 Dec 15.

PMID:
24334644
50.

Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan.

Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T.

Mod Rheumatol. 2014 May;24(3):464-70. doi: 10.3109/14397595.2013.843765. Epub 2013 Nov 5.

PMID:
24252039

Supplemental Content

Loading ...
Support Center